NCT02163278View on ClinicalTrials.gov

A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

DBPR108

DBPR108 capsules in four doses beginning at 25 mg and rising to 600 mg.

DRUG

matching placebo

Matching placebo capsules in four doses beginning at 25 mg and rising to 600 mg.

Trial Locations (1)

11031

Taipei Medical University - Taipei Medical University Hospital, Taipei

All Listed Sponsors
lead

National Health Research Institutes, Taiwan

OTHER

NCT02163278 - A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter